Structure of the bacterial synthesis apparatus
To understand the sites of action of protein synthesis inhibitors in detail, one must have a clear picture of the structural components of the bacterial translational apparatus. The bacterial ribosome consists of two parts: the small (30S subunit) and the large (50S subunit).
Within this complex structure, there are two key functional centers where the main events take place:
- A-site (aminoacyl center) — a "landing zone" and entry point for a new transfer RNA (tRNA) carrying the next amino acid for the growing protein.
- P-site (peptidyl center) — the site where the growing peptide chain is securely held.
The protein assembly process itself is based on information encoded in messenger RNA (mRNA). The ribosome reads this genetic material strictly in one direction: from the 5' end to the 3' end.
Action on the small 30S subunit
The first group of drugs interferes with the initial stages of interaction between messenger RNA and the small ribosomal subunit.
- Aminoglycosides target the 30S subunit specifically. By binding to it, they cause a spatial distortion of the ribosomal structure. The primary consequence of this is incorrect reading of the mRNA code. The ribosome starts making errors, completely wrong amino acids are incorporated into the synthesized chain, and ultimately defective proteins incapable of performing their functions are produced.
- Tetracyclines block the initiation phase of elongation. Their site of action is the A-site on the 30S subunit. These drugs strictly block the binding of tRNA to this center. As a result, a new transfer RNA carrying the required amino acid physically cannot attach to the ribosomal complex, completely halting further elongation of the peptide chain.
Action on the large 50S subunit
The second group of antibiotics affects enzymatic processes and the mechanical movement of the ribosome by binding to the large 50S subunit.
- Chloramphenicol (also known as levomycetin) inhibits the transpeptidation phase. It acts on the enzymatic center of the 50S subunit, blocking peptidyl transferase. Because of this, the transfer of the growing peptide chain from the tRNA located in the P-site to the new amino acid in the A-site becomes impossible. The formation of the peptide bond stops.
- Macrolides are responsible for inhibiting the translocation phase. Normally, the ribosome must move along the mRNA by exactly one triplet (codon). Macrolides, by binding to the 50S subunit, block this movement. As a result, the A-site is not freed to accept the next tRNA, and the "empty" spent tRNA cannot leave the P-site. Further protein synthesis becomes impossible.
Physiology of translation termination
Under physiological conditions, the elongation phase (chain lengthening) is a strict sequence of repeating cycles. Key steps of each such cycle include: binding of aminoacyl-tRNA to the A-site, followed by peptide bond formation, and finally translocation. Translocation involves the movement of the growing peptide, which gradually exits through a special exit tunnel of the ribosome.
The end of protein synthesis is called termination. This stage occurs when one of the stop codons (UAA, UAG, or UGA) appears in the A-site. Special proteins — termination factors (or release factors) — "recognize" this stop codon and activate the final processes. The result of termination is the release of the fully synthesized protein molecule and the dissociation (disintegration) of the ribosome-mRNA complex.
Briefly: answers to topical questions
Which antibiotic groups bind to the large 50S ribosomal subunit?
The following protein synthesis inhibitors bind to the large 50S ribosomal subunit:
- Macrolides — site of action: 50S subunit; mechanism: inhibition of translocation.
- Ketolides — act on the 50S subunit; telithromycin has a higher affinity for the 50S subunit and binds to an additional site on the 23S rRNA.
- Lincosamides — target: ribosomal 50S subunit; inhibit protein synthesis at the translocation stage / block peptide bond formation.
- Chloramphenicol — site of action: 50S subunit; causes peptidyl transferase blockade.
- Linezolid — binds to the P-site of the ribosomal 50S subunit and blocks the formation of the initiation complex.
- Quinupristin/dalfopristin — target: ribosomal 50S subunit; block peptidyl transferase, disrupt translocation, and inhibit the exit of the elongating peptide chain from the ribosome.
What is the mechanism of action of lincosamides?
The mechanism of action of lincosamides involves the inhibition of intracellular protein synthesis at the translocation stage. The target of these drugs is the 50S subunit of the bacterial ribosome. By binding to it, lincosamides block peptide bond formation, which stops the elongation of the peptide chain. In terms of their site of action, they are similar to macrolides, which leads to competitive antagonism for ribosomal binding when used together.
Which protein synthesis inhibitors have a bactericidal type of action?
Among protein synthesis inhibitors, only a few drug groups possess a bactericidal type of action.
- Aminoglycosides — are an exception among protein synthesis inhibitors, exerting irreversible inhibition and a bactericidal effect.
- Combination drugs (quinupristin/dalfopristin) — act bactericidally on most gram-positive bacteria.
- Lincosamides — have a predominantly bacteriostatic effect, although at high concentrations they can exhibit a bactericidal effect.
What mechanisms of bacterial resistance to macrolides exist?
There are four main mechanisms of bacterial resistance to macrolides:
- Enzymatic inactivation — production of esterases that hydrolyze macrolides; characteristic of enterococci.
- Target modification — alteration of the ribosomal binding site structure via chromosomal mutations or methylation; methylase modifies the macrolide binding site on the ribosome.
- Impaired transport — reduced cell membrane permeability or active efflux of the drug from the cell.
- Cross-resistance (MLS phenotype) — constitutive production of methylase provides resistance to macrolides, lincosamides, and group B streptogramins.
For quick memorization of the sites of action, use the rule: Aminoglycosides and Tetracyclines bind to the small 30S subunit. Macrolides and Chloramphenicol attack the large 50S subunit.
Class and exam questions
At what stage of protein synthesis do tetracyclines act?
They block the initiation phase of elongation. The drug binds to the A-site of the small 30S subunit and prevents the attachment of new transfer RNA.
What is the result of aminoglycosides binding to the ribosome?
They distort the shape of the 30S subunit. This causes incorrect reading of messenger RNA, leading the bacterium to synthesize defective proteins with incorrect amino acids.
What is the core mechanism of action of macrolides?
Macrolides inhibit translocation — the movement of the ribosome along the mRNA. As a result, the A-site remains occupied, and the next amino acid cannot enter the cycle.
Which antibiotic blocks peptidyl transferase?
Chloramphenicol (levomycetin). It binds to the enzymatic center of the 50S subunit and halts the transpeptidation reaction (peptide bond formation).
What else to study on this topic
- Mechanism of action of lincosamides on the bacterial cell
- The role of release factors in the process of translation termination
- Features of the growing peptide exit through the ribosomal tunnel
- Cyclical nature of the elongation phase in bacterial protein synthesis
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Protein synthesis-disrupting antibiotics" and 5,304 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Antibacterial Chemotherapeutic Agents"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.